Navigation Links
Fujitsu Announces PalmSecure(TM) LOGONDIRECTOR
Date:9/9/2008

Seamless Integration of Palm Vein Authentication Technology with Single-Sign On Solutions Cost-Effectively Bolsters Security and Compliance

Efforts by Eliminating Passwords

SUNNYVALE, Calif., Sept. 9 /PRNewswire/ -- Fujitsu Computer Products of America, Inc., a leading supplier of innovative computer products including hard disk drives, peripherals and biometric security solutions, today announced the availability of the PalmSecure LOGONDIRECTOR, a new addition to identity management solutions that combines Fujitsu's PalmSecure biometric authentication technology embedded into a PC mouse, and software that seamlessly integrates with any vendor's single sign-on (SSO) solution. By combining highly accurate, non-intrusive identification technology with SSO connectivity, the LOGONDIRECTOR eliminates the need to remember passwords, providing both the SMB and enterprise market with a stronger user authentication solution to bolster security and facilitate compliance with HIPAA, SOX and other industry regulations.

"There is a definite need to move to a more efficient and secure form of user authentication rather than simply inputting passwords in the SMB and enterprise sectors," said Joel Hagberg, vice president, marketing and business development, Fujitsu Computer Products of America, Inc. "The PalmSecure LOGONDIRECTOR eliminates the need to remember countless passwords and provides companies with a superior form of strong authentication technology and significant time and cost savings."

Passwords present numerous problems for companies from both a security and cost perspective. "Shoulder surfing," a common practice where perpetrators steal passwords by looking over the shoulder of the victim, poses a critical threat for identity theft. Moreover, IT departments traditionally spend numerous hours re-assigning new passwords to employees who forget their log-in information, which translates into cost that often exceeds t
'/>"/>

SOURCE Fujitsu Computer Products of America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
2. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
3. Fujitsu Announces Industry Highest Capacity 2.5 Inch SATA Hard Disk Drive at 320GB(1)
4. Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States
5. Fujitsu Combines Capacity, Performance and Power Efficiency Into the Industrys First 320GB 7200 RPM 2.5" Sata Hard Disk Drive
6. Fujitsu Scanners Selected as Editors Choice in Better Buys for Business 2008 Scan-to-File Guide
7. Fujitsu PalmSecure(TM) Wins Network Products Guide 2008 Reader Trust Award
8. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
9. LaserCard Corporation Announces Expansion of Middle East Project
10. BIO-key(R) Announces Contracts for New Criminal Justice Data Sharing Solution
11. Balzan Foundation announces 2007 winners

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...9, 2009 / b3c newswire / - Today, TNO, a Dutch ...an American organization for contract research and...ned a letter of intent with regard to TNOs dynamic...r of intent proposes a collaboration in which Seve...lization in North America. The TIM systems will be...
(Date:11/9/2009)...stry leaders from around the world will gather in ...lecular Targets and Cancer Therapeutics Internatio...information on important cancer therapies in devel...reat it effectively we need a greater understandin...r level," said Lewis Cantley, Ph.D., director of t...
(Date:11/8/2009)...hers at Purdue University have discovered a new ap...l cord injuries using nano-spheres that could be i..., The synthetic "copolymer micelles" are drug-de... roughly 100 times smaller than the diameter of a ... how to deliver drugs for cancer treatment and oth...
Breaking Biology News(10 mins):TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 1InVitria Reports Successful Cell Culture Performance of Zap CHO a Defined and Cost Effective CHO Cell Culture Media Supplement 60242 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 1NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 2NeuroVasx Announces First Case of cPAX Aneurysm Treatment System in Spain 60238 3Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 1Health Partners to Offer Health Insurance Through the Childrens Health Insurance Program 60234 2
... When Yadong Wang, a chemist by training, first ve...idn,t know that his peers would have considered hi...cuits use electrical signals often conducted by ne...te between the brain and the rest of the body, he ...ed to repair a broken circuit. The neurotransmitte...
... University of Manchester researchers are recruiti...?commonly known as sciatica ?in the first ever stu...their condition. , Dr Christopher McCarthy and his...n Science need 30 volunteers aged 22-55 who have h...nt and have not had previous spinal surgery. , ...
... Using the latest in high tech tools, researchers ...edictive of chronic lung rejection up to 20 months...patients have the highest mortality rate of organ ...nvestigator and pulmonologist Chris Wendt. Current...splants will fail, and when signs of chronic rejec...
Other Biology News:Dopamine used to prompt nerve tissue to regrow 2Proteins may predict lung transplant rejection 2Proteins may predict lung transplant rejection 3
(Date:11/6/2009)...Newswire-FirstCall/ -- Helix BioPharma Corp. (TSX,...that John Docherty, president and chief operating ...h annual Investor Summit on November 10, 2009 at 4... Docherty will provide an overview of the Company,... Topical Interferon Alpha-2b. The slide show port...
(Date:11/6/2009)...PRNewswire-FirstCall/ -- ,, 3Q09 Corporate H...TM) E.U. Marketing Authorization to Astellas Pharm...rcial readiness activities Expanded management te...; and Director, Commercial Operations Appointed B...Committee chairman , Upcoming 2009 Mileston...
(Date:11/6/2009)...Newswire/ -- Intarcia Therapeutics, Inc. delivered...74; continuous delivery of exenatide) program for ...al Diabetes Technology Meeting in San Francisco, C...nh/20050301/SFTU126LOGO ) ,, Continuous Subcu...Plasma Glucose, HbA1c and Reduces Weight in a 28-d...
(Date:11/5/2009)...PRNewswire-FirstCall/ -- GenVec, Inc. (Nasdaq: GN... third quarter ended September 30, 2009. GenVec re...) for the three months ended September 30, 2009 co...are) in the comparable quarter of 2008. For the ni...oss was $14.1 million ($0.15 per share), compared ...
Breaking Biology Technology:Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
...RDAM, The Netherlands, February 18 ,Amsterdam Mole...e field of,human gene therapy, announced today tha...ll year 2008 on Tuesday, February 24, 2009 at 7:00...results, the Company will,conduct a conference cal... for the Netherlands is 0800-949-4166 (toll free)....
...b., Feb. 18 Transgenomic Inc. (OTC Bulletin Board...hat: Transgenomic Inc. Fourth Quarter 2008 Ear...en: Wednesday, February 25, 2009 @ 5:00 p.m. E...vents.asp?id=6 , How: Live over the Intern... address above., , , To access the call via te...
...ES, Feb. 18 The Board of Directors wishes to conf...y 4, 2009 it resolved to file a Form 15 with effec...t require the approval of stockholders but in the ...olders informed the Board is making this Release. ...ompany from its United States Securities and Excha...
Other Biology Technology:AMT to Release Full Year 2008 Results on February 24, 2009 2Webcast Alert: Transgenomic Inc. Announces Fourth Quarter 2008 Earnings Release Conference Call Webcast 2EESTECH Inc - Release From SEC Filing 2EESTECH Inc - Release From SEC Filing 3EESTECH Inc - Release From SEC Filing 4
SILVER SEQUENCE Staining Reagents from Promega
Sheep Anti-Decorin Polyclonal Antibody, Unconjugated from Abcam
Mouse Complement from Equitech-Bio
...S-4P, all Programmable and Digital Orbital Shaker.... been redesigned to make every day use even easier...memory for up to 4 different programs. Its easy re...am. Furthermore, the VSOS-4P has a pulse operation...
Biology Products: